Atlas Trials

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Clinical trial NCT06250829 · UNKNOWN

Trial details

NCT number
NCT06250829
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Status
UNKNOWN
Study type
OBSERVATIONAL
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
Start date
2023-10-12
Primary completion
2024-10-30
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.